CIDRAP newsletters options
Symptoms overall declined in a year, but some had symptoms for the first time at 6 and 12 months.
Studies describe mpox in 158 women and 5 cases of severe disease following Jynneos vaccination.
Nocebo is a phenomenon in which people experience negative effects when they have negative views or expectations.
A measles outbreak in the Columbus, Ohio, area has expanded to 50 cases.
Venezuela reports its first detection of highly pathogenic H5N1 avian flu in wild birds.
During shortages of 5 antibiotics at a US children's hospital, prescribers adhered to restriction protocols 57% of the time.
An FDA official wants drug companies to start reporting spikes in demand in an effort to prevent or ease shortages.
Shortages of some drugs to treat kids' respiratory illnesses come amid surges of RSV and the flu and continuing COVID-19.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Dec 1
The US Food and Drug Administration (FDA) announced yesterday that it has approved a fecal microbiota product for the prevention of recurrent Clostridioides difficile infection (CDI) in adults.
As hospitalizations almost double, most states are experiencing high or very high flu levels.
Antibiotic use on European farms has fallen 43.2%, compared with 30.4% in the US.
Given CWD's incubation period, it's possible the case is connected to a 2021 finding at an illegal dump site.
The study highlights a likely high rate of asymptomatic disease spread.
"It is clear that ... healthcare services and policy need to prioritise long Covid care."
The Democratic Republic of the Congo, Indonesia, and Yemen reported polio cases.
Data reflect about an 11% incidence of residual lung damage known as interstitial lung disease after COVID-19 hospitalization.
Commercial farms in Missouri, South Dakota, Illinois, and Maryland were hit in the most recent outbreaks.
Africa CDC said African countries are seeing a replay of COVID-19 vaccine deployment.
Attending classes online was more stressful than in-person or hybrid instruction.
Approval of Rebyota, made by Ferring Pharmaceuticals, was based on findings from multiple randomized clinical trials.
